U
Nutri Pharmaceuticals Research, Inc. NRPR
$0.021 $0.005535.48%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2003
Total Cash And Short-Term Investments 90.10K
Total Receivables 125.00K
Inventory 259.10K
Prepaid Expenses --
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 474.10K

Total Current Assets 474.10K
Net Property, Plant & Equipment 197.30K
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 4.50K
Total Assets 676.00K

Total Accounts Payable 192.60K
Total Accrued Expenses 48.70K
Short-term Debt 83.60K
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current 42.30K
Total Finance Division Other Current Liabilities 70.40K
Total Other Current Liabilities 70.40K
Total Current Liabilities 437.60K

Total Current Liabilities 437.60K
Long-Term Debt --
Short-term Debt 83.60K
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 437.60K

Common Stock & APIC 548.80K
Retained Earnings -188.20K
Treasury Stock & Other -122.20K
Total Common Equity 238.40K

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity 238.40K
Total Preferred Equity --
Total Minority Interest --
Total Equity 238.40K

Weiss Ratings